A Randomized Phase III Study of Sublobar Resection (SR) versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Non-small Cell Lung Cancer
  • Age: Between 18 - 99 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:

    1.  Patient must have radiographic findings consistent with non-small cell lung cancer, including lesion with ground glass opacities with a solid component of 50% or greater.


    2.  Patient must have a tumor = 4cm maximum diameter, including clinical stage IA and selected IB by PET/CT scan of the chest and upper abdomen


    3.  Patient must have tumor located peripherally within the lung, and verified by a thoracic surgeon to be in a location that will permit a sublobar resection

You may not be eligible for this study if the following are true:

  • 1.  Patients with prior intra-thoracic radiation therapy; previous chemotherapy or surgical resection specifically for the lung cancer being treated


    2.  Patients with prior lung resection on the same side

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.